281 related articles for article (PubMed ID: 11914885)
1. Dose selection for radioiodine therapy of borderline hyperthyroid patients with multifocal and disseminated autonomy on the basis of 99mTc-pertechnetate thyroid uptake.
Reinhardt MJ; Joe A; von Mallek D; Zimmerlin M; Manka-Waluch A; Palmedo H; Krause TM
Eur J Nucl Med Mol Imaging; 2002 Apr; 29(4):480-5. PubMed ID: 11914885
[TBL] [Abstract][Full Text] [Related]
2. Dose selection for radioiodine therapy of borderline hyperthyroid patients according to thyroid uptake of 99mTc-pertechnetate: applicability to unifocal thyroid autonomy?
Reinhardt MJ; Biermann K; Wissmeyer M; Juengling FD; Brockmann H; von Mallek D; Ezziddin S; Joe AY; Krause TM
Eur J Nucl Med Mol Imaging; 2006 May; 33(5):608-12. PubMed ID: 16541268
[TBL] [Abstract][Full Text] [Related]
3. [First results of radioiodine therapy of multifocal and disseminated thyroid gland autonomy and use of a TcTUs-adapted dose concept].
Oexle C; Reinhardt M; Moser E
Nuklearmedizin; 1998; 37(6):192-6. PubMed ID: 9770712
[TBL] [Abstract][Full Text] [Related]
4. Improved dose concept for radioiodine therapy of multifocal and disseminated functional thyroid autonomy.
Reinhardt M; Emrich D; Krause T; Bräutigam P; Nitzsche E; Blattmann H; Schümichen C; Moser E
Eur J Endocrinol; 1995 May; 132(5):550-6. PubMed ID: 7749494
[TBL] [Abstract][Full Text] [Related]
5. [Radioiodine therapy of funcitonal autonomy using the functional autonomous volume].
Seeger T; Emrich D; Sandrock D
Nuklearmedizin; 1995 Aug; 34(4):135-40. PubMed ID: 7675642
[TBL] [Abstract][Full Text] [Related]
6. [Results of TcTUs-optimized radioiodine therapy in multifocal and disseminated autonomy].
Dunkelmann S; Endlicher D; Prillwitz A; Rudolph F; Groth P; Schümichen C
Nuklearmedizin; 1999; 38(5):131-9. PubMed ID: 10488479
[TBL] [Abstract][Full Text] [Related]
7. Radioiodine therapy in Graves' disease based on tissue-absorbed dose calculations: effect of pre-treatment thyroid volume on clinical outcome.
Reinhardt MJ; Brink I; Joe AY; Von Mallek D; Ezziddin S; Palmedo H; Krause TM
Eur J Nucl Med Mol Imaging; 2002 Sep; 29(9):1118-24. PubMed ID: 12192554
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of factors affecting treatment results for toxic goiter with radioactive 131I].
Listewnik MH
Ann Acad Med Stetin; 2000; 46():109-21. PubMed ID: 11712298
[TBL] [Abstract][Full Text] [Related]
9. Scintigraphic evaluation of functional thyroidal autonomy.
Meller J; Becker W
Exp Clin Endocrinol Diabetes; 1998; 106 Suppl 4():S45-51. PubMed ID: 9867196
[TBL] [Abstract][Full Text] [Related]
10. TcTU before and after exogeneous TSH suppression in diagnosing thyroid autonomy.
Kreisig T; Pickardt CR; Kirsch CM; Knesewitsch P
Acta Med Austriaca; 1990; 17 Suppl 1():54-5. PubMed ID: 2167603
[TBL] [Abstract][Full Text] [Related]
11. Radioiodine treatment of hyperthyroidism in cats: results of 165 cats treated by an individualised dosing algorithm in Spain.
Xifra P; Serrano SI; Peterson ME
J Feline Med Surg; 2022 Aug; 24(8):e258-e268. PubMed ID: 35748791
[TBL] [Abstract][Full Text] [Related]
12. [Radioiodine therapy of functional autonomy of the thyroid gland. Treatment results in view of pretreatment scintigraphic diagnosis and early response of triiodothyronine levels to treatment].
Langhammer HR; Laubenbacher C; Hirsch C; Klingele C; Spyra JL; Senekowitsch-Schmidtke R; Schwaiger M
Med Klin (Munich); 1999 Aug; 94(8):415-24. PubMed ID: 10495620
[TBL] [Abstract][Full Text] [Related]
13. [Global 99mTc uptake in the differential diagnosis of a normal thyroid,goiter with euthyroidism and thyroid autonomy in an area of iodine deficiency].
Kreisig T; Pickardt CR; Horn K; Bechtner G; Vaitl C; Kirsch CM; Knesewitsch P
Nuklearmedizin; 1990 Jun; 29(3):113-9. PubMed ID: 2168038
[TBL] [Abstract][Full Text] [Related]
14. Scintigraphy with 99mTc-pertechnetate in the evaluation of functional thyroidal autonomy.
Meller J; Becker W
Q J Nucl Med; 1999 Sep; 43(3):179-87. PubMed ID: 10568133
[TBL] [Abstract][Full Text] [Related]
15. Iodine isotope ¹³¹I therapy for toxic nodular goitre: treatment efficacy parameters.
Szumowski P; Rogowski F; Abdelrazek S; Kociura-Sawicka A; Sokolik-Ostasz A
Nucl Med Rev Cent East Eur; 2012 Apr; 15(1):7-13. PubMed ID: 23047567
[TBL] [Abstract][Full Text] [Related]
16. Radioiodine therapy for Plummer's disease based on the thyroid uptake of technetium-99m pertechnetate.
Meller J; Wisheu S; Munzel U; Behe M; Gratz S; Becker W
Eur J Nucl Med; 2000 Sep; 27(9):1286-91. PubMed ID: 11007508
[TBL] [Abstract][Full Text] [Related]
17. EVALUATION OF QUANTITATIVE THYROID SCINTIGRAPHY FOR DIAGNOSIS AND STAGING OF DISEASE SEVERITY IN CATS WITH HYPERTHYROIDISM: COMPARISON OF THE PERCENT THYROIDAL UPTAKE OF PERTECHNETATE TO THYROID-TO-SALIVARY RATIO AND THYROID-TO-BACKGROUND RATIOS.
Peterson ME; Guterl JN; Rishniw M; Broome MR
Vet Radiol Ultrasound; 2016 Jul; 57(4):427-40. PubMed ID: 27062212
[TBL] [Abstract][Full Text] [Related]
18. Pertechnetate uptake in the prediction of early outcome after radioiodine therapy.
Gimlette TM
Nuklearmedizin; 1989 Feb; 28(1):21-5. PubMed ID: 2540481
[TBL] [Abstract][Full Text] [Related]
19. Comparison of different thyroid committed doses in radioiodine therapy for Graves' hyperthyroidism.
Grosso M; Traino A; Boni G; Banti E; Della Porta M; Manca G; Volterrani D; Chiacchio S; AlSharif A; Borsò E; Raschillà R; Di Martino F; Mariani G
Cancer Biother Radiopharm; 2005 Apr; 20(2):218-23. PubMed ID: 15869459
[TBL] [Abstract][Full Text] [Related]
20. The continuing importance of thyroid scintigraphy in the era of high-resolution ultrasound.
Meller J; Becker W
Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S425-38. PubMed ID: 12192542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
